The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years.
Excessive sweating in the hands, medically known as palmar hyperhidrosis, is a problem that affects many people and can cause discomfort in social, work, or everyday situations. According to health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results